Found 492 matching trials
Extension Study to Assess Batoclimab in Participants With Thyroid Eye Disease PHASE3 This is a 2-cohort (observational and treatment cohort) extension study for...
Show More Location
Site Number - 1520
Learn More & Join Trial
Safety Study of an Intravenous Staphylococcus Aureus Immune Globulin (Human), [Altastaph] in Low-Birth-Weight-Neonates PHASE2 The main objective will be to test the safety of two intravenous infusions ...
Show More Location
Multiple Locations
Learn More & Join Trial
Clinical Trial to Evaluate the Efficacy and Safety of Codivir® in Addition to Standard Antiretroviral Treatment for HIV Infection in Antiretroviral-naïve Participants PHASE2 The study will begin with a two-week lead-in period (W-2 and W-1), when par...
Show More Location
RDSS Research Center
Learn More & Join Trial
A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001) PHASE3 The purpose of this protocol is to evaluate the efficacy of tulisokibart in...
Show More Status
Active Not Recruiting
Location
Digestive Health Specialists ( Site 0135)
Learn More & Join Trial
Thymalfasin-based PRaG Mode for Advanced Refractory Solid Tumors PHASE2 This is an open-label, single-arm, Phase II investigator-initiated trial of...
Show More Location
The Second Affiliated Hospital of SchoowUniversity
Learn More & Join Trial
Safety and Efficacy Study of Flebogamma 5% DIF IGIV in Pediatric Subjects PHASE4 This is a multi-center, open-label study to assess the efficacy and safety ...
Show More Location
University of South Florida
Learn More & Join Trial
A Study of Trastuzumab Subcutaneous in Participants With Human Epidermal Growth Factor Receptor-2 (HER2) Positive Early Breast Cancer N/A This observational study will evaluate the efficacy, safety, tolerability a...
Show More Location
Universitätsmedizin Mainz; Klinik u. Poliklinik f. Geburtshilfe u. Frauenheilkunde
Learn More & Join Trial
A Study of Subcutaneous KY1005 in Healthy Volunteers PHASE1 Single centre, open-label, single dose, parallel group study to investigate...
Show More Location
Hammersmith Medicines Research
Learn More & Join Trial
A Pilot Trial To Assess The Feasibility And Efficacy Of SCIG In Patients With MG Exacerbation (SCIG-MG) PHASE3 This is a prospective open-label, uncontrolled, single-blind, pilot clinica...
Show More Location
University of Alberta
Learn More & Join Trial
A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer PHASE3 This is a Phase IIIb, multinational, multicenter, randomized, open-label st...
Show More Location
Centro de Investigaciones Médicas y Desarrollo LC S.R.L
Learn More & Join Trial